Background Preliminary data suggests that favipiravir might have a role in COVID-19 treatment.
Our aim was to assess the role of favipiravir in the treatment of COVID-19. Methods A …

It is with great sadness that we report the death of Mike Richardson at the age of 69 on 3rd
November 2004. Mike was one of the true pioneers of thermal analysis especially in the use …

Background: Preliminary data suggests that favipiravir might have a role in COVID-19 treatment.
Our aim was to assess the role of favipiravir in the treatment of COVID-19. Methods: A …

Data suggests that favipiravir (FVP) could be used against SARS-CoV-2. Our aim was to
investigate the role of FVP in COVID-19 treatment. A prospective sequential cohort study was …

… 27 Erre a Volksaufklärung kontextusában Kovács Ákos András is utalt: „A társadalom
alávetettnek tekintett csoportjai az ilyen és ehhez hasonló diskurzusokban válnak egyre inkább a …

Background: Nearly 10% of COVID-19 cases will require admission to the intensive care
unit (ICU). Our aim was to assess the clinical and microbiological outcomes of secondary …

Objectives Emerging evidence suggests that remdesivir might improve clinical outcome of
high-risk outpatients with COVID-19. Our aim was to evaluate characteristics and outcomes of …

Objectives Our aim was to compare outcomes of hospitalized adults with severe COVID-19
and cytokine storm treated with tocilizumab or baricitinib. Methods A prospective, …

Background: The optimal approach for adult patients hospitalized with severe and critical
coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory …

Baricitinib is considered a first-line treatment for severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2)-infected adult patients with an associated cytokine storm syndrome (…